Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice.

Gomez-Nicola D, Spagnolo A, Guaza C, Nieto-Sampedro M.

Exp Neurol. 2010 Apr;222(2):235-42. doi: 10.1016/j.expneurol.2009.12.034. Epub 2010 Jan 11.

PMID:
20070942
3.

IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis.

Liu R, Bai Y, Vollmer TL, Bai XF, Jee Y, Tang YY, Campagnolo DI, Collins M, Young DA, La Cava A, Shi FD.

Exp Neurol. 2008 May;211(1):14-24. doi: 10.1016/j.expneurol.2007.11.004. Epub 2007 Nov 22.

PMID:
18353312
4.

Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.

Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z.

J Neurosci Res. 2005 Mar 1;79(5):680-93.

PMID:
15682385
5.

Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.

Zhang GX, Yu S, Gran B, Li J, Siglienti I, Chen X, Calida D, Ventura E, Kamoun M, Rostami A.

J Immunol. 2003 Nov 1;171(9):4485-92.

6.

Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.

Berard JL, Wolak K, Fournier S, David S.

Glia. 2010 Mar;58(4):434-45. doi: 10.1002/glia.20935.

PMID:
19780195
7.

IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.

Tran EH, Prince EN, Owens T.

J Immunol. 2000 Mar 1;164(5):2759-68.

8.

Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.

Lu Z, Hu X, Zhu C, Wang D, Zheng X, Liu Q.

J Neuroimmunol. 2009 Jan 3;206(1-2):58-69. doi: 10.1016/j.jneuroim.2008.10.014. Epub 2008 Dec 9.

PMID:
19081144
10.

Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis.

Natarajan C, Muthian G, Barak Y, Evans RM, Bright JJ.

J Immunol. 2003 Dec 1;171(11):5743-50. Erratum in: J Immunol. 2004 Apr 15;172(8):following 5127.

12.

Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis.

Pagenstecher A, Lassmann S, Carson MJ, Kincaid CL, Stalder AK, Campbell IL.

J Immunol. 2000 May 1;164(9):4481-92.

13.

CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis.

Teige A, Teige I, Lavasani S, Bockermann R, Mondoc E, Holmdahl R, Issazadeh-Navikas S.

J Immunol. 2004 Jan 1;172(1):186-94.

14.

IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.

Teige I, Treschow A, Teige A, Mattsson R, Navikas V, Leanderson T, Holmdahl R, Issazadeh-Navikas S.

J Immunol. 2003 May 1;170(9):4776-84.

15.

Resistance to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis by death receptor 6-deficient mice.

Schmidt CS, Zhao J, Chain J, Hepburn D, Gitter B, Sandusky G, Chintalacharuvu S, Glasebrook A, Na S.

J Immunol. 2005 Aug 15;175(4):2286-92.

16.

IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.

Klein RS, Izikson L, Means T, Gibson HD, Lin E, Sobel RA, Weiner HL, Luster AD.

J Immunol. 2004 Jan 1;172(1):550-9.

17.

Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice.

Tan SL, Zhao J, Bi C, Chen XC, Hepburn DL, Wang J, Sedgwick JD, Chintalacharuvu SR, Na S.

J Immunol. 2006 Mar 1;176(5):2872-9.

18.

p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis.

Bullard DC, Hu X, Adams JE, Schoeb TR, Barnum SR.

Am J Pathol. 2007 Jun;170(6):2001-8.

19.

IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis.

Weir C, Bernard CC, Bäckström BT.

Int Immunol. 2003 Nov;15(11):1283-9.

PMID:
14565926
20.

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y.

J Immunol. 2006 Jul 1;177(1):566-73.

Supplemental Content

Support Center